Hepatitis Monthly

Published by: Kowsar

Molecular Epidemiology of Different Hepatitis C Genotypes in Serum and Peripheral Blood Mononuclear Cells in Jahrom City of Iran

Asghar Ashrafi Hafez 1 , Rasoul Baharlou 2 , Seyed Dawood Mousavi Nasab 3 , Abbas Ahmadi Vasmehjani 2 , * , Mohammad Shayestehpour 4 , Negar Joharinia 2 and Nayeb Ali Ahmadi 5
Authors Information
1 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Jahrom University of Medical Sciences, Jahrom, IR Iran
3 Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
4 Department of Virology, Tehran University of Medical Sciences, Tehran, IR Iran
5 Department of Medical Lab Technology and Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e16391
  • Published Online: May 11, 2014
  • Article Type: Research Article
  • Received: December 23, 2013
  • Accepted: May 13, 2014
  • DOI: 10.5812/hepatmon.16391

To Cite: Ashrafi Hafez A, Baharlou R, Mousavi Nasab S D, Ahmadi Vasmehjani A, Shayestehpour M, et al. Molecular Epidemiology of Different Hepatitis C Genotypes in Serum and Peripheral Blood Mononuclear Cells in Jahrom City of Iran, Hepat Mon. 2014 ; 14(5):e16391. doi: 10.5812/hepatmon.16391.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902): 359-62[PubMed]
  • 2. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis. 2006; 43(10): 1277-83[DOI][PubMed]
  • 3. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol. 2007; 13(17): 2461-6[PubMed]
  • 4. Alberti AB, Benhamou JP, Blei A, Reichen J, Rizzetto M. textbook of Hepatology: From Basic Science to Clinical Practice. 2007;
  • 5. Alavian SM. We need a new national approach to control hepatitis C: It is becoming too late. Hepat Mon. 2008; 8(3): 1-3
  • 6. Brown RS, Jr, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003; 9(11)-3[DOI][PubMed]
  • 7. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006; 12(43): 7025-8[PubMed]
  • 8. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology. 2014; 59(1): 318-27[DOI][PubMed]
  • 9. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005; 42(4): 962-73[DOI][PubMed]
  • 10. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, et al. The origin of hepatitis C virus genotypes. J Gen Virol. 1997; 78 ( Pt 2): 321-8[PubMed]
  • 11. Hadziyannis SJ, Sette H, Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004; 140(5): 346-55[PubMed]
  • 12. Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, et al. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis. 2005; 192(2): 258-65[DOI][PubMed]
  • 13. Trimoulet P, Bernard PH, de Ledinghen V, Oui B, Chene G, Saint-Marc Girardin MF, et al. Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha. Dig Dis Sci. 2000; 45(1): 175-81[PubMed]
  • 14. Majda-Stanislawska E, Bednarek M, Jozwiak B, Sidorkiewicz M, Piekarska A, Kuydowicz J. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C. Acta Gastroenterol Belg. 2006; 69(2): 187-90[PubMed]
  • 15. Xu DZ, Xie Y, Li ZQ. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int. 2005; 4(4): 550-3[PubMed]
  • 16. Laskus T, Radkowski M, Wang LF, Nowicki M, Rakela J. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol. 2000; 74(2): 1014-7[PubMed]
  • 17. Di Liberto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, Samuel D, et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology. 2006; 131(1): 76-84[DOI][PubMed]
  • 18. Vera-Otarola J, Barria MI, Leon U, Marsac D, Carvallo P, Soza A, et al. Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naive chronically infected patients. J Viral Hepat. 2009; 16(9): 633-43[DOI][PubMed]
  • 19. Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, Mayer KH, et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis. 2007; 195(12): 1765-73[DOI][PubMed]
  • 20. Castillo I, Rodriguez-Inigo E, Bartolome J, de Lucas S, Ortiz-Movilla N, Lopez-Alcorocho JM, et al. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut. 2005; 54(5): 682-5[DOI][PubMed]
  • 21. Gong GZ, Lai LY, Jiang YF, He Y, Su XS. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol. 2003; 9(2): 291-4[PubMed]
  • 22. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol. 2010; 16(16): 2005-9[PubMed]
  • 23. Antonishyn NA, Ast VM, McDonald RR, Chaudhary RK, Lin L, Andonov AP, et al. Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J Clin Microbiol. 2005; 43(10): 5158-63[DOI][PubMed]
  • 24. Mohamad HI, El-Bab HK, Kamal AM. HCV RNA in serum and peripheral blood mononuclear cells after successful interferon therapy. Hepatogastroenterology. 2011; 58(107-108): 932-6[PubMed]
  • 25. Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, et al. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Jpn J Infect Dis. 2007; 60(1): 29-32[PubMed]
  • 26. Hanno AFF, Mohiedeen KM, Alshayeb AF, Deghedy A. HCV RNA in peripheral blood mononuclear cells (PBMCs) as a predictor of the response to antiviral therapy in chronic hepatitis C. Alexandria J Med. 2013; 50(1)[DOI]
  • 27. White PA, Li Z, Zhai X, Marinos G, Rawlinson WD. Mixed viral infection identified using heteroduplex mobility analysis (HMA). Virology. 2000; 271(2): 382-9[DOI][PubMed]
  • 28. Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, deGiacomo M, et al. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis. 2007; 195(1): 124-33[DOI][PubMed]
  • 29. Di Liberto G, Feray C. The anhepatic phase of liver transplantation as a model for measuring the extra-hepatic replication of hepatitis C virus. J Hepatol. 2005; 42(4): 441-3[DOI][PubMed]
  • 30. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 1994; 343(8894): 388-90[PubMed]
  • 31. Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlam CA, Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis. 1994; 170(4): 1018-22[PubMed]
  • 32. Falcón V, Acosta-Rivero N, Shibayama M, Chinea G, Gavilondo JV, de la Rosa MC, et al. Evidences of hepatitis C virus replication in hepatocytes and peripheral blood mononuclear cells from patients negative for viral RNA in serum. Am J Infect Dis . 2005; 1(1): 34-42[DOI]
  • 33. Carreno V, Bartolome J, Castillo I, Quiroga JA. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol. 2008; 18(3): 139-57[DOI][PubMed]
  • 34. Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, et al. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon. 2013; 13(8)[DOI][PubMed]
  • 35. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011; 83(6): 989-95[DOI][PubMed]
  • 36. Farahani M, Bokharaei-Salim F, Ghane M, Basi A, Meysami P, Keyvani H. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders. J Med Virol. 2013; 85(2): 235-40[DOI][PubMed]
  • 37. Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010; 39(3): 284-91[DOI][PubMed]
  • 38. Comar M, Dal Molin G, D'Agaro P, Croce SL, Tiribelli C, Campello C. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol. 2006; 59(5): 526-9[DOI][PubMed]
  • 39. Giannini C, Giannelli F, Zignego AL. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology. 2006; 43(5): 1166-7[DOI][PubMed]
  • 40. Holland PV, Barrera JM, Ercilla MG, Yoshida CF, Wang Y, de Olim GA, et al. Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol. 1996; 34(10): 2372-8[PubMed]
  • 41. Isobe K, Imoto M, Fukuda Y, Koyama Y, Nakano I, Hayakawa T, et al. Hepatitis C virus infection and genotypes in Japanese hemophiliacs. Liver. 1995; 15(3): 131-4[PubMed]
  • 42. Telfer PT, Devereux H, Savage K, Scott F, Dhillon AP, Dusheiko G, et al. Chronic hepatitis C virus infection in haemophilic patients: clinical significance of viral genotype. Thromb Haemost. 1995; 74(5): 1259-64[PubMed]
  • 43. Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol. 2012; 157(10): 1959-65[DOI][PubMed]
  • 44. Qian KP, Natov SN, Pereira BJ, Lau JY. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat. 2000; 7(2): 153-60[PubMed]
  • 45. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002; 36(5 Suppl 1)-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments